FIELD: medicine.
SUBSTANCE: invention refers to a soft capsule containing a compound, causing irritation in oral cavity, particularly, (2R)-2-propyloctane acid or its salt. Said compounds are suitable as an agent to prevent, treat and/or delay of progression of symptoms of various neurodegenerative diseases. The capsule exhibits durability 150 to 400 H when crack-tested, decay time 3 to 10 minutes when disintegration tested.
EFFECT: soft capsule under the invention is chewing-resistant, it can be ingested safely without sensation of burning, hotness, pain in oral cavity; the capsule ensures long storage without solubility delay.
34 cl, 24 tbl, 8 ex
Authors
Dates
2010-03-20—Published
2005-06-10—Filed